Programming Degradation and Drug Release Through Micropatterning of PLGA Films

Area of Science:

• Biomaterials Science
• Polymer Chemistry
• Drug Delivery Systems

Background:

• Polymeric films offer controlled drug release, enhancing therapeutic outcomes and minimizing side effects.
• Current research often focuses on material composition rather than physical structure.
• Geometric control presents an underexplored avenue for tuning film properties.

Purpose of the Study:

• To investigate the impact of film geometry on degradation and drug release kinetics.
• To evaluate the role of surface area-to-volume ratio (Sa/V) in micropatterned poly(lactic-co-glycolic acid) (PLGA) films.
• To establish geometry as a primary design parameter for implantable polymeric films.

Main Methods:

• Fabrication of micropatterned PLGA films (μMESH) with varying square opening sizes (5-50 μm) and a control solid film (FLAT).
• Characterization of surface area-to-volume ratios (Sa/V) for each film geometry.
• Assessment of PLGA mass loss (erosion) and molecular weight reduction (degradation) over time in vitro.
• In vivo evaluation of film structural retention and docetaxel release profiles.

Main Results:

• Erosion and degradation rates strongly correlated with Sa/V (r=0.99 and r=0.92, respectively).
• Higher Sa/V films exhibited slower degradation and prolonged structural retention (μMESH with 20 μm openings maintained integrity for >60 days).
• Docetaxel release kinetics were biphasic and showed increased cumulative release with higher Sa/V (r=0.97).

Conclusions:

• Film geometry alone, specifically Sa/V, is a powerful tool for precisely controlling PLGA film degradation, erosion, and drug release.
• Micropatterning offers a robust strategy for designing implantable polymeric films with tailored performance characteristics.
• This geometric control approach provides a new paradigm for optimizing drug delivery systems.